Antisera raised against porcine neuropeptide Y (NPY) and peptide YY (PYY) were characterized with regard to immunohistochemical staining, cross-reactivity to several pancreatic polypeptide (PP)-related peptides, and radioimmunoassayable tissue levels in the rat and pig. The NPY antiserum (102B) reacted with nerves in many areas of both the central and peripheral nervous systems, but it did not stain endocrine cells of the pancreas or intestine. No evidence for any cross-reactivity of the NPY antiserum with related peptides of the PP family, such as avian PP, bovine PP, PYY, T-MSH, FMRF-amide, or avian PP (31-36), was obtained. The NPY antiserum was N-terminally directed, and regional levels of NPY as seen by radioimmunoassay paralleled well the occurrence of NPY-immunoreactive structures seen in the immunohistochemical study. High pressure liquid chromatography analysis revealed that the NPY-immunoreactive material from cerebral cortex and vas deferens had elution profiles similar to those of standard porcine NPY. The PYY antiserum mainly stained endocrine cells in the pancreas and intestine as well as a small neuron system in the brainstem of the rat. Although this antiserum had a slight cross-reactivity to NPY in radioimmunoassay, the neuronal PYY staining was separate from that of NPY. High levels of PYY were found in the intestine, and levels above the threshold were also seen in the dorsal vagal complex of the rat. The other antisera investigated (raised against avian PP, bovine PP, r-MSH, and FMRF-amide) caused neuronal staining that was abolished by preabsorption with NPY. This was also seen even if no detectable cross-reactivity with NPY was found in radioimmunoassay. These latter antisera also stained endocrine cells in the pancreas and intestine with complex cross-reactivity relationships, suggesting the presence of intestinal PP-like peptides in addition to PYY and NPY.
Pancreatic polypeptide (PP) was originally isolated from bovine (Lin and Chance, 1974) and avian pancreas (Kimmel et al., 1975 of 36 positions. These peptides were demonstrated early with immunohistochemistry in a special type of endocrine cell of the Langerhans islets (Larsson et al., 1976) . Subsequently, it was found that antisera raised against APP, BPP, or the carboxyterminal hexapeptide of BPP also induced immunostaining of the central and peripheral nervous systems including some catecholaminergic nerves (Lo& et al., 1979; Lundberg et al., 1980; Hakfelt et al., 1981; Hunt et al, 1981; Olschowka et al., 1981; Jacobowitz and Olschowka, 1982; Taylor and Vaillant, 1983) . However, we and others (Gu et al., 1983; J. R. Kimmel and P. Emson, personal communications) failed to measure immunoreactivity with different APP antisera by radioimmunoassay (RIA) .
The isolation of peptide YY (PYY), another member of the PP family in intestinal extracts (the peptide (P) with NHP-and COOH-terminal tyrosine (Y)) (Tatemoto, 1982a) , raised the possibility that this was the neuronal peptide reacting with various PP antisera in the immunohistochemical analysis. However, this did not appear to be the case, since PYY was found to occur in endocrine cells, mainly in distal intestine (Lundberg et al., 1982c) . Recently, extracts of porcine brain (Tatemoto et al., 1982; Tatemoto, 1982b) were found to contain another peptide, neu- 2376 The Journal of Neuroscience Neuropeptide Y and PP-immunoreactive Nerves 2377 ropeptide Y (NPY, the neuronal (N) peptide (P) with COOHterminal tyrosine (Y)) with extensive structural similarities to the other PP-related peptides. NPY, PYY, APP, and BPP have in fact around 20 of 36 amino acids in identical positions, and many exchanges seem to be compensating; i.e., they occur between structurally similar amino acids. When antisera were subsequently raised to NPY, they were found to react essentially with the same nervous structures as previously recognized with APP or BPP antisera (Lundberg et al., 1982b , Gu et al., 1983 Hokfelt et al., 1983; SundIer et al., 1983; Everitt et al., 1984) . Thus, catecholamine neurons in several species including humans contained NPY-immunoreactive (IR) material (Hiikfelt et al., 1973; Lundberg et al., 1982b, c; Everitt et al., 1984) . Evidence for the adrenergic nature of these nerves was their staining with antisera raised to tyrosine hydroxylase, dopamine @hydroxylase, or phenylethanolamine-N-methyltransferase, which are markers for catecholaminergic neurons (see Hokfelt et al., 1973 ) and a loss of NPY immunoreactivity in many peripheral organs, including vas deferens and heart, induced by 6-hydroxydopamine (6-OHDA) pretreatment (Lundberg et al., 1982b) . However, both in the central and peripheral nervous systems there seem to exist, in addition, extensive non-catecholaminergic NPY-IR systems. In the periphery this is indicated, for instance, by the demonstration of local NPY-IR neurons resistant to 6-OHDA pretreatment in, for example, the intestine (Lundberg et al., 1982b; see also Sundler et al., 1983) .
described earlier (Tatemoto, 1882a, b) . Synthetic NPY was obtained from Bachem (Torrence, CA). APP and BPP were purified and generously donated by Prof. J. Kimmel (VA Medical Center, Kansas City, In the present study we have used specific antisera with high affinity for porcine NPY and PYY, respectively, in RIA and for immunohistochemistry. Levels of NPY and PYY, as measured by RIA, were compared with the results of immunohistochemistry. Special care was given to possible cross-reaction between these peptides and a series of related peptides (APP, BPP, r-MSH, and FMRF-amide).
Materials and Methods
Zmmunohistochemietry. Male rats (body weight 150 to 250 gm) and juvenile pigs (body weight 25 to 30 kg) were studied. The rats were anesthetized with Nembutal(50 mg/kg, i.p.) and perfused intracardially with ice-cold saline for 30 set followed by ice-cold 10% formalin (Pease, 1962) for 20 min. The brain and peripheral tissues were dissected out and immersed in the same fixative for 90 min. Alternatively, after the saline rinse, small tissue pieces from the brain and some peripheral organs were dissected out, sliced, and immersion-fixed for 2 hr in an ice-cold phosphate buffer (0.05 M, pH 7.4), containing 2% formalin and 0.25% parabenzoquinone (PBQ) (Lundberg et al., 1982a) . The pigs were anesthetized with Nembutal (50 mg/kg, i.v.), and brain and peripheral tissues were immersed in either 10% formalin or the formalin/PBQ mixture described above for 2 to 4 hr. After either type of fixation the tissues were rinsed with buffered 5% sucrose for at least 24 hr and then sectioned on a cryostat. Fourteen-micrometer thick sections were cut and incubated for 24 hr at +4"C with antisera to norcine NPY (102B). norcine PYY (69C) (Lundbere et al.. 1982b) . APP (68D), BPP (417; lot 615-RllO-146-16, donated bi Dr. R: Chance; Eli Lilly and Co., Indianapolis, IN), synthetic -r-MSH(l-11) (85C), and synthetic FMRF-amide (469; donated by Prof. R. Elde, Department of Anatomy, University of Minnesota Medical School, Minneapolis, MN). The following working dilutions of antisera were used: NPY, 1:400; PYY, 1:lOO; APP, 1:200; BPP, 1:200; and FMRF-amide, 1800. Following incubation for 24 hr at +4"C and rinsing, the sections were incubated with a fluorescein isothiocyanate (FITC) (Dakopats, Copenhagen, Denmark)-labeled swine-anti-rabbit antiserum diluted 1:lO for 30 min at 37" C. The sections were subsequently rinsed, mounted in a mixture of glycerin and phosphate buffer containing 0.2% paraphenylenediamine (see Giloh and Sedat,. 19821 , and examined in a Zeiss fluorescence microscope equipped with filter for optimal FITC detection. To study the specificity of the immunostaining and cross-reactivity of the antisera with related peptides, adjacent sections were incubated with antisera that had been preabsorbed with various peptides for 24 hr at +4"C (see "Results"). The preabsorption experiments were repeated twice and coded sections were studied by two independent observers.
NPY and porcine PYY were obtained using the isolation procedure MO) and Dr. R. Chance. T-MSH(l-11) and FMRF-amide were p&i chased from Peninsula Laboratories (Belmont, CA). APP(31-36) was obtained by custom synthesis from Merseyside Laboratories (Warrington, England).
Biochemical methods. NPY isolated from porcine brain (Tatemoto 1982a) was used for immunization and preparation of labeled tracer. For immunization, 280 pg of NPY were coupled to 2.2 mg of bovine thyroglobulin (Sigma Chemical Co., St. Louis, MO) by the addition of 53 pg of 1-ethyl-3-dimethyl-aminopropylcarbodiimide (Sigma). The reaction was carried out in 0.4 ml of H,O under gentle agitation for 20 hr at room temperature and terminated by the addition of 200 ~1 of 2 M hydroxylamine (Merck, Darmstadt, Federal Republic of Germany). The reaction mixture was dialyzed twice against 2 liters of physiological saline. The conjugate concentration was adjusted to 70 rg of peptide/ ml. For immunization, this solution was emulsified with an equal volume of Freund's complete adjuvant. Each rabbit received doses corresponding to 50 pg of peptide intradermally on the back at 30 to 40 sites. Booster doses of conjugate corresponding to 50 Fg of peptide were then given after about 2 months and then at monthly intervals by subcutaneous injections at the mamillary line of conjugate emulsified with Freund's incomplete adjuvant. Three or more booster injections were necessary to give good titers.
Iodination of NPY was carried out with the chloramine T nrocedure in a 0.1 M phosphate buffer with a reaction time of 10 min'(pH 7.5), using Iodobeads (Pierce Chemical Co., Rockford, IL). For 1 nmol of peptide, 0.5 mCi of NaI'*' was used. The reaction product was fractionated by high pressure liquid chromatography (HPLC) on a pBondapak (Waters Associates, Milford, MA) C-18 reversed phase silica gel column, using 35% acetonitrile and 0.04% trifluoroacetic acid in water as eluent. The eluted produce showed a complex elution pattern (there are five tyrosine residues in the molecule), and the peak with oligolabeled material was collected (Fig. 1) .
For RIA, antiserum 102B at 1:20,000 to 1:50,000 final dilution and about 5,000 cpm '*'I-NPY was incubated for 24 hr at 4°C in 225 ~1 of buffer (0.05 M sodium phosphate, pH 7.5, 0.15 M NaCl, 0.02% sodium azide. 0.1% gelatin. 0.1% bovine serum albumin (BSA). and 0.1% Triton X-106). Alternatively, the extracts were incubated for 48 hr with antiserum, followed by subsequent addition of tracer and incubation for another 72 hr. . Elution pattern of radioactivity (volume, 10 ~1) after labeling of NPY with the chloramine T procedure. Besides free iodide which elutes in the first few fractions, there are several peaks of radioactivity. There is probably progressive increase in the molecular ratio of iodine to peptide with increasing elution volume. In RIA, the early peak (shaded area) gave the best results. The elution volume of unlabeled NPY is also indicated. Vol. 4, No. 9, Sept. 1984 Instruments, Palo Alto, CA) for 2.5 min, and 300 bl of supernatant were counted in a gamma counter. A standard curve was prepared and the iodinated NPY was considered adequate, if the apparent Kn was less than low9 M. To study further the characteristics of the NPY antiserum, tryptic fragments of NPY , , and NPY (26-33), each about 10 nmol) were prepared and isolated by HPLC, as described earlier (Tatemoto, 198213) . Frozen specimens to be analyzed were cut into small fragments and added to a Potter-Elvehjelm homogenizer containing 20 vol of 1 M acetic acid kept at 95°C. After 5 min, the homogenizer was cooled, the tissues were homogenized, and then the homogenizer was heated to 95°C for another 5 min. The homogenates were centrifuged at 10,000 x g for 20 min, and the supernatants were collected and kept for a few days at -90°C until analysis. The extracts were then separated on an SP-Sephadex C-25 cation exchanger prior to the RIA, as earlier described for analysis of PYY (Lundberg et al., 198213; see also Bergstriim et al., 1983) . A suitable number of ion exchange columns were prepared, using a l-ml ion exchanger in silanized Pasteur pipettes. 
Results

Immunohistochemical analysis
In the present study, attention was focused on some brain areas and peripheral tissues which, as shown in this and previous studies (Lundberg et al., 1982c; Allen et al., 1983; Hijkfelt et al., 1973; 1983; Everitt et al., 1984) ,'contain numerous NPY-IR neurons (see below). These tissues were investigated on adjacent sections, using antisera to NPY and related peptides (see Fig. 2 ). Incubation with several of these antisera (raised against NPY, APP, BPP, y-MSH, or FMRF-amide) resulted in very similar staining patterns in certain areas and tissues, for example vas deferens (Fig. 3) and the rostra1 nucleus tractus solitarii.
However, the intensity of the staining could vary considerably between different antisera (Fig. 3 , Table I ).
NPY antiserum 102B. NPY-IR neurons were abundant in both central and peripheral nervous systems of rat and pig. Thus, NPY-IR cells and/or fibers were seen in the cerebral cortex (Fig. 4, a and b) , hypothalamus ( Fig. 4c) , some areas of the medulla oblongata (e.g., nucleus tractus solitarii and lateral reticular nucleus) (Fig. 4d) , sympathetic ganglia ( Fig. 4e) , vas deferens (Figs. 2a and 5a), pancreas (Fig. 4f) , and colon (Fig.  4g) . No endocrine cells in the pancreas (Fig. 4f) and colon ( Fig.  4g) were NPY-IR.
Preabsorption results are summarized in Table I (A to C). Absorption of NPY antiserum with NPY abolished the immunostaining (Fig. 5b) , whereas absorption with lOO-to lOOOfold excess of APP (Fig. 5c) , ( Fig. 5d) , BPP, y-MSH, FMRF-amide (Fig. 5e) , PYY (Fig. 5f ), and neurotensin had no effect (Table I, Fig. 5 ). In RIA the NPY antiserum did not show any significant (<O.l%) cross-reactivity to APP, PYY, FMRF-amide, T-MSH, and neurotensin.
The antiserum seems to be directed to the NHz-terminal end of the peptide, since the tryptic fragment NPY(l-19) showed high (-20%) competitive affinity, whereas the fragments (NPY(20-25), NPY(26-33)) did not cross-react. The NPY antiserum showed similar cross-reactivity to natural and synthetic porcine NPY (Fig. 6 ). APP antiserum (68 D). The APP antiserum stained nerves with a distribution very similar to that observed with the NPY antiserum (Fig. 36 ). In addition, some endocrine cells in the Langerhans islets of the pancreas, but not in the colon, were APP-IR.
The APP immunoreactivity in nerves tias strongly reduced by NPY preabsorption but not by any of the other PPrelated peptides (Table I) . However, the APP staining of endocrine cells in the pancreas was not reduced by NPY (Table  I ). In RIA, the APP antiserum was partially displaced by NPY at lo-fold higher concentrations (Fig. 7) , and there was also slight (1%) cross-reactivity with BPP. oblongata of the rat. In addition, the PYY antiserum stained endocrine cells in rat pancreas and in the colon of both the rat and the pig (Fig. 4h) . No PYY-IR nerves were seen in the hypothalamus or in the vas deferens (Fig. 3d) . The PYY staining of nerves or endocrine cells was not abolished by preabsorption with NPY or any other PP-related peptide (Table I) . However, APP(31-36) preabsorption reduced the intensity of the PYY immunoreactivity in both nerves and endocrine cells (Table I ). In RIA the PYY antiserum had a slight crossreactivity to BPP (1%) and to NPY (0.5%), but not to any other PP-related peptide ((0.1%).
r-M&W antiserum (85 C). The -y-MSH antiserum stained nerves in areas similar to those stained by the NPY antiserum (Fig. 3f) Fig. 3e) with an NPY-like distribution in addition to endocrine cells in the pancreas and colon. Preabsorption of the FMRF-amide antiserum with NPY, APP, BPP, PYY, and y-MSH markedly reduced or abolished the immunostaining of both nerves and endocrine cells (Table I ).
Biochemical analysis
The detection limit of the RIA for NPY using 24-hr incubation was -50 fmol/tube, whereas sequential addition of the tracer increased the sensitivity to about 10 fmol/tube (Fig. 6) . Tissue extracts were fractioned on ion exchange columns prior to RIA analysis. The relevant fractions caused concentrationdependent displacement of [9]NPY. The displacement curves for rat vas deferens were parallel to those of the standard (Fig.   6 ).
HPLC analysis of NPY-IR material from pig and rat cortex and vas deferens revealed an elution volume very similar to that of standard natural porcine NPY. Material from the rat peaked slightly earlier than did porcine NPY (Fig. 8, a and b) . In the rat cortex, there was also evidence for some NPY-IR peaks, which eluted earlier than the standard (Fig. 8) . The major NPY peaks were clearly separated from that of standard natural porcine PYY. The levels of NPY and PYY in some brain areas and peripheral organs of the pig and rat, as measured by RIA, are given inTable II. Especially high levels of NPY were observed in the hypothalamus and vas deferens of the rat and in the cortex of the pig. The NPY levels in the cerebellum were below or close to the detection limit. In the rat significant amounts of PYY in the central nervous system, assuming a cross-reaction in the RIA with NPY of 0.5% (i.e., low NPY to PYY ratio), were observed in the nucleus of the tractus solitarius (Table I) . On the other hand, high levels of PYY were found in the pancreas, (Table II) . RIA for APP revealed no detectable immunoreactivity in brain, vas deferens, or a variety _ Discussion of other rat tissues, although the APP antiserum had high 'l'he present findings establish NPY as a naturally occurring affinity for APP (Kn < lo-" M).
neuropeptide in widespread systems in the CNS and periphery. This conclusion is based on the following observations. (I) The NPY antiserum does not cross-react with any other PP-like peptide tested, neither as analyzed with RIA nor with the high concentrations of antiserum used in immunohistochemistry. The lack of significant cross-reactivity between the NPY antiserum and other PP peptides was further substantiated by the observation that the antiserum did not stain endocrine cells of the pancreas (i.e., PP cells) or colon (PYY cells), i.e., structures which contain comparatively high levels of PP-related peptides. (2) There was a good correlation between the density and distribution pattern of NPY neurons, as observed with immunofluorescence histochemistry, and of the concentration of NPY as measured by RIA. This is in marked contrast to the results with the APP antiserum, which gives rise to strong immunostaining but fails, when used in RIA, to react with any endogenous material (see also Gu et al., 1983) . (3) There was identical chromatographic behavior in HPLC analysis of material extracted from porcine vas deferens and brain reacting in RIA for NPY, and the authentic standard. HPLC analysis of material from the rat indicated some heterogeneity but with the main peak eluting rather close to porcine NPY. There was a very clear chromatographic separation from PYY. (4) The fact that other antisera (against PP peptides, y-MSH, and FMRF-amide) not primarily directed against NPY gave neuronal staining patterns similar to those obtained with NPY antiserum might be explained by cross-reaction with NPY at the immunocytochemical level. Particularly, the APP antiserum showed marked cross-reaction with NPY in RIA. It therefore seems likely that earlier reports on neuronal staining with antisera against APP or BPP (Lo&n et al., 1979; Lundberg et al., 1980 Lundberg et al., , 1982a Hunt et al., 1981; Jacobowitz and Olschowka, 1982) in several areas can be explained by reaction with NPY.
Recently, J. R. Kimmel (personal communication) has succeeded in purifying rat PP and raised antiserum against the peptide. Preliminary work with this antiserum has revealed a moderately strong staining of rat neurons with a distribution similar to the NPY-IR ones. This staining was blocked by NPY (10m5 M), whereas NPY-like immunoreactivity (102B) was not affected by preabsorption with rat PP (unpublished observations).
The levels of NPY that we have measured in certain areas of rat brain are in partial agreement with those recently reported by Allen et al. (1983) . Thus, they found about 180 pmol/ gm of wet weight in cortex and 700 to 1000 pmol in hypothalamus. However, our levels were lower in the caudate, where they reported the NPY content to be more than 300 pmol compared to our 75 to 150 pmol, and in cerebellum, which they reported as 27 pmol, compared to our values close to the detection limit (< 1 to 4 pmol/gm).
One possible explanation for our lower levels is that we are using an ion exchange procedure prior to the RIA, which removes material interfering in the RIA.
FMRF-amide and r-MSH have a certain structural homology since they both terminate in Arg-Phe-amide. Furthermore, the cross-reaction of the y-MSH and FMRF-amide antisera to the PP-related peptides may be explained by the structural similarities of the C-terminal Arg-Phe-NH* and Arg-Tyr-NH, sequences. However, it should be remembered that FMRFamide has been isolated from a mollusc (Price and Greenberg, 1977) and that the corresponding peptide in rat brain may be structurally different. Dockray and Williams (1983) found evidence for two peptides reacting with FMRF-amide antiserum in rat brain, and more recently they identified a pentapeptide, LPLRF-amide (Leu-Pro-Leu-Arg-Phe-NH& in chicken brain (Dockray et al., 1983) . The FMRF-amide antiserum used by Dockray and Williams (1983) showed considerable cross-reactivity with APP but not with NPY under RIA conditions. Unfortunately, we do not have corresponding information for the FMRF-amide antiserum used here. The immunohistochemical observation of a cross-reactivity of NPY for the y-MSH antiserum was not supported by crossreaction in the RIA. Direct testing to determine whether ['251] NPY was bound to the antiserum was negative. Thus, there is no direct evidence that some minor population of antibodies in the r-MSH antiserum is reacting with NPY. This observation stresses the importance of preabsorption controls in immuno- histochemical analysis even if RIA with many fold higher dilutions of antiserum does not reveal any significant crossselective antibodies with reasonable affinity had been available to us. reactivity. This kind of problem is probably going to be more
The presence of PYY immunoreactivity in endocrine cells of acute, if the immunostained peptide occurs in large quantity. the pancreas and intestine of several species confirms earlier On the other hand, when cross-reactivity was observed in RIA results (Lundberg et al., 1982b) . Here, PYY immunoreactivity it also seemed to extend to immunohistochemistry.
The diffwas also seen in nerve fibers of the brainstem of the rat. This culties encountered here might have been avoided if more did not seem to be due to cross-reaction with NPY. RIA also In conclusion, the present findings point to a high degree of structural complexity and diversity of PP-like peptides in neurons and endocrine cells. NPY appears as an important neuropeptide considering both its wide distribution and high levels. Although the present results do not support a major occurrence % binding Lundbe rg et al. Vol. 4, No. 9, Sept. 1984 in the spinal cord and spinal trigeminal nucleus. Peptides 2: 82-87. of other members of the PP family in the nervous system, this should be further analyzed. In the gastrointestinal tract, peptides of the PP family are present in at least three systems, with PP proper, NPY, and PYY, respectively. Clarification of the complicated occurrence of PP-related peptides will require knowledge about the protein prohormones and their processing to smaller molecular forms and the access to specific antibodies for immunohistochemistry.
